• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HEDD:人类表观遗传药物数据库。

HEDD: the human epigenetic drug database.

作者信息

Qi Yunfeng, Wang Dadong, Wang Daying, Jin Taicheng, Yang Liping, Wu Hui, Li Yaoyao, Zhao Jing, Du Fengping, Song Mingxia, Wang Renjun

机构信息

Department of Bioscience, School of Life Science, Jilin Normal University, Siping, China

Department of Computer Science and Technology, Computer College, Jilin Normal University, Siping, China.

出版信息

Database (Oxford). 2016 Dec 26;2016. doi: 10.1093/database/baw159. Print 2016.

DOI:10.1093/database/baw159
PMID:28025347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5199199/
Abstract

Epigenetic drugs are chemical compounds that target disordered post-translational modification of histone proteins and DNA through enzymes, and the recognition of these changes by adaptor proteins. Epigenetic drug-related experimental data such as gene expression probed by high-throughput sequencing, co-crystal structure probed by X-RAY diffraction and binding constants probed by bio-assay have become widely available. The mining and integration of multiple kinds of data can be beneficial to drug discovery and drug repurposing. HEMD and other epigenetic databases store comprehensively epigenetic data where users can acquire segmental information of epigenetic drugs. However, some data types such as high-throughput datasets are not provide by these databases and they do not support flexible queries for epigenetic drug-related experimental data. Therefore, in reference to HEMD and other epigenetic databases, we developed a relatively comprehensive database for human epigenetic drugs. The human epigenetic drug database (HEDD) focuses on the storage and integration of epigenetic drug datasets obtained from laboratory experiments and manually curated information. The latest release of HEDD incorporates five kinds of datasets: (i) drug, (ii) target, (iii) disease, (vi) high-throughput and (v) complex. In order to facilitate data extraction, flexible search options were built in HEDD, which allowed an unlimited condition query for specific kinds of datasets using drug names, diseases and experiment types.Database URL: http://hedds.org/.

摘要

表观遗传药物是一类化合物,它们通过酶作用于组蛋白和DNA的无序翻译后修饰,并通过衔接蛋白识别这些变化。与表观遗传药物相关的实验数据,如通过高通量测序探测的基因表达、通过X射线衍射探测的共晶体结构以及通过生物测定探测的结合常数,已广泛可得。多种数据的挖掘和整合有助于药物发现和药物重新利用。HEMD等表观遗传数据库全面存储表观遗传数据,用户可以获取表观遗传药物的片段信息。然而,这些数据库并未提供一些数据类型,如高通量数据集,并且它们不支持对表观遗传药物相关实验数据进行灵活查询。因此,参考HEMD和其他表观遗传数据库,我们开发了一个相对全面的人类表观遗传药物数据库。人类表观遗传药物数据库(HEDD)专注于存储和整合从实验室实验获得的表观遗传药物数据集以及人工整理的信息。HEDD的最新版本纳入了五种数据集:(i)药物,(ii)靶点,(iii)疾病,(iv)高通量和(v)复合物。为了便于数据提取,HEDD内置了灵活的搜索选项,允许使用药物名称、疾病和实验类型对特定类型的数据集进行无限制条件查询。数据库网址:http://hedds.org/

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/5199199/b11a40b34448/baw159f3p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/5199199/32c5ed81e025/baw159f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/5199199/98d10393878f/baw159f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/5199199/b11a40b34448/baw159f3p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/5199199/32c5ed81e025/baw159f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/5199199/98d10393878f/baw159f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/5199199/b11a40b34448/baw159f3p.jpg

相似文献

1
HEDD: the human epigenetic drug database.HEDD:人类表观遗传药物数据库。
Database (Oxford). 2016 Dec 26;2016. doi: 10.1093/database/baw159. Print 2016.
2
HHMD: the human histone modification database.HHMD:人类组蛋白修饰数据库。
Nucleic Acids Res. 2010 Jan;38(Database issue):D149-54. doi: 10.1093/nar/gkp968. Epub 2009 Nov 5.
3
HEMD: an integrated tool of human epigenetic enzymes and chemical modulators for therapeutics.HEMD:一种用于治疗的人类表观遗传酶和化学调节剂的综合工具。
PLoS One. 2012;7(6):e39917. doi: 10.1371/journal.pone.0039917. Epub 2012 Jun 25.
4
GED: a manually curated comprehensive resource for epigenetic modification of gametogenesis.GED:一个经过人工整理的配子发生表观遗传修饰综合资源库。
Brief Bioinform. 2017 Jan;18(1):98-104. doi: 10.1093/bib/bbw007. Epub 2016 Feb 5.
5
MetaImprint: an information repository of mammalian imprinted genes.MetaImprint:哺乳动物印记基因信息库。
Development. 2014 Jun;141(12):2516-23. doi: 10.1242/dev.105320. Epub 2014 May 21.
6
dbEM: A database of epigenetic modifiers curated from cancerous and normal genomes.dbEM:一个从癌基因组和正常基因组中筛选出的表观遗传修饰因子数据库。
Sci Rep. 2016 Jan 18;6:19340. doi: 10.1038/srep19340.
7
Ontology development for a pharmacogenetics knowledge base.药物遗传学知识库的本体开发。
Pac Symp Biocomput. 2002:65-76.
8
Epigenetic drug discovery: systematic assessment of chemical space.表观遗传学药物发现:化学空间的系统评估。
Future Med Chem. 2019 Nov;11(21):2803-2819. doi: 10.4155/fmc-2019-0096. Epub 2019 Nov 8.
9
Pedican: an online gene resource for pediatric cancers with literature evidence.Pedican:一个具有文献证据的儿科癌症在线基因资源。
Sci Rep. 2015 Jun 15;5:11435. doi: 10.1038/srep11435.
10
DiseaseMeth: a human disease methylation database.疾病甲基化数据库:一个人类疾病甲基化数据库。
Nucleic Acids Res. 2012 Jan;40(Database issue):D1030-5. doi: 10.1093/nar/gkr1169. Epub 2011 Dec 1.

引用本文的文献

1
Recent Advances in Therapeutic Peptides: Innovations and Applications in Treating Infections and Diseases.治疗性肽的最新进展:在治疗感染和疾病中的创新与应用
ACS Omega. 2025 Apr 23;10(17):17087-17107. doi: 10.1021/acsomega.5c02077. eCollection 2025 May 6.
2
Epigenetic Mechanisms in the Transfer of Metabolic Disorders: A Comprehensive Review.代谢紊乱传递中的表观遗传机制:综述
Cureus. 2025 Mar 11;17(3):e80418. doi: 10.7759/cureus.80418. eCollection 2025 Mar.
3
A Computational Approach for the Discovery of Novel DNA Methyltransferase Inhibitors.

本文引用的文献

1
Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.贝利司他用于治疗复发或难治性外周T细胞淋巴瘤。
J Oncol Pharm Pract. 2017 Mar;23(2):143-147. doi: 10.1177/1078155216634178. Epub 2016 Jun 23.
2
Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma.帕比司他:复发或难治性多发性骨髓瘤的综述
Target Oncol. 2016 Feb;11(1):107-14. doi: 10.1007/s11523-015-0413-6.
3
Predicting target proteins for drug candidate compounds based on drug-induced gene expression data in a chemical structure-independent manner.
一种用于发现新型DNA甲基转移酶抑制剂的计算方法。
Curr Issues Mol Biol. 2024 Apr 16;46(4):3394-3407. doi: 10.3390/cimb46040213.
4
Gastric Cancer in the Era of Epigenetics.《表观遗传学时代的胃癌》
Int J Mol Sci. 2024 Mar 16;25(6):3381. doi: 10.3390/ijms25063381.
5
Potential of melatonin to reverse epigenetic aberrations in oral cancer: new findings.褪黑素逆转口腔癌表观遗传异常的潜力:新发现
EXCLI J. 2023 Dec 12;22:1280-1310. doi: 10.17179/excli2023-6624. eCollection 2023.
6
Promises and challenges in pharmacoepigenetics.药物表观遗传学中的承诺与挑战。
Camb Prism Precis Med. 2023 Feb 9;1:e18. doi: 10.1017/pcm.2023.6. eCollection 2023.
7
Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?中枢神经系统疾病治疗中的表型药物:一种可行的方法?
Cells. 2023 May 24;12(11):1464. doi: 10.3390/cells12111464.
8
An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.表观遗传学药物治疗癌症和脑部疾病的最新进展:全面综述。
Genes (Basel). 2023 Apr 6;14(4):873. doi: 10.3390/genes14040873.
9
A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis.一种系统基因组学方法,用于揭示溃疡性结肠炎中患者特异性的致病途径和蛋白质。
Nat Commun. 2022 Apr 28;13(1):2299. doi: 10.1038/s41467-022-29998-8.
10
Epigenetics-Associated Risk Reduction of Hematologic Neoplasms in a Nationwide Cohort Study: The Chemopreventive and Therapeutic Efficacy of Hydralazine.一项全国性队列研究中与表观遗传学相关的血液肿瘤风险降低:肼苯哒嗪的化学预防和治疗效果
Front Oncol. 2022 Feb 2;12:809014. doi: 10.3389/fonc.2022.809014. eCollection 2022.
基于药物诱导的基因表达数据以化学结构无关的方式预测候选药物化合物的靶蛋白。
BMC Med Genomics. 2015 Dec 18;8:82. doi: 10.1186/s12920-015-0158-1.
4
Drug target prioritization by perturbed gene expression and network information.基于基因表达扰动和网络信息的药物靶点优先级排序
Sci Rep. 2015 Nov 30;5:17417. doi: 10.1038/srep17417.
5
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology.2015年的BindingDB:一个用于药物化学、计算化学和系统药理学的公共数据库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D1045-53. doi: 10.1093/nar/gkv1072. Epub 2015 Oct 19.
6
PubChem Substance and Compound databases.美国国立医学图书馆化学物质数据库和化合物数据库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D1202-13. doi: 10.1093/nar/gkv951. Epub 2015 Sep 22.
7
Epigenetic Drug Discovery: Great Potential and Significant Challenges.
Assay Drug Dev Technol. 2015 May;13(4):185. doi: 10.1089/adt.2015.29000.rcu.
8
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.特定分子特征可预测慢性粒单核细胞白血病对地西他滨的反应。
J Clin Invest. 2015 May;125(5):1857-72. doi: 10.1172/JCI78752. Epub 2015 Mar 30.
9
The proposed rule for U.S. clinical trial registration and results submission.美国临床试验注册及结果提交的拟议规则。
N Engl J Med. 2015 Jan 8;372(2):174-80. doi: 10.1056/NEJMsr1414226. Epub 2014 Dec 24.
10
OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders.OMIM.org:《人类孟德尔遗传在线》(OMIM®),一个人类基因和遗传疾病的在线目录。
Nucleic Acids Res. 2015 Jan;43(Database issue):D789-98. doi: 10.1093/nar/gku1205. Epub 2014 Nov 26.